Moleculin Biotech, Inc. Share Price
NASDAQ: MBRXMoleculin Biotech, Inc. Stock Performance
Moleculin Biotech, Inc. Share Price Today
As of 11 October 2026, Moleculin Biotech, Inc.'s share price is $0.45. The stock opened at $0.43, compared to its previous close of $0.42. During today's trading session, Moleculin Biotech, Inc.'s share price traded between $0.43 and $0.45, with an average price of $0.44. Over the past 52 weeks, the stock has recorded a high of $7.84 and a low of $0.16. In terms of performance, Moleculin Biotech, Inc.'s share price has declined by 82.54% over the last six months and is down 4.28% on a year-on-year basis.
Moleculin Biotech, Inc. Share Price Chart
Moleculin Biotech, Inc. Quarterly Profit & Loss
All figures in USD
Moleculin Biotech, Inc. Annual Profit & Loss
All figures in USD
About Moleculin Biotech, Inc.
Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.
Moleculin Biotech, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.51 | $0.45 | -10.60% |
Sep 2026 | $0.64 | $0.50 | -27.43% |
Aug 2026 | $0.34 | $0.69 | +72.25% |
Jul 2026 | $2.62 | $0.40 | -85.69% |
Jun 2026 | $2.85 | $2.79 | +0.18% |
May 2026 | $2.51 | $2.79 | +8.98% |
Apr 2026 | $2.25 | $2.56 | +12.78% |
Mar 2026 | $2.42 | $2.27 | -5.81% |
Feb 2026 | $4.30 | $2.41 | -42.96% |
Jan 2026 | $3.32 | $4.22 | +28.22% |
Dec 2025 | $6.29 | $3.29 | +1,124.91% |
Nov 2025 | $0.46 | $0.27 | -42.40% |